Altogether, our findings show that overexpression of miR-634 leads to direct repression of RSK2, CCND1, GRB2 and ERK2 in ovarian cancer cell lines and ovarian cancer cells derived from patients. Here, RPS6KA3 is linked to ovarian cancer.